Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Micronised progesterone crossover trial in transfeminine adults on estradiol
ACTRN12620001364965Phase 4Not yet recruiting
- Sponsor
- Austin Health
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of progesterone in gender dysphoria (GD), sleep disorder and anxiety disorder (2 arms), sponsored by Austin Health. Primary endpoint: Sleep quality. Planned start Jan 2021; status: not yet recruiting.
02
Drugs
progesterone
03
Conditions
gender dysphoria (GD)sleep disorderanxiety disorder
Beyond the preview
Go deeper on ACTRN12620001364965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12620001364965.